I
n 2000, two landmark papers started a revolution in our ability to design entirely new functions inside cells. The authors took two electronic circuits -an oscillator and a switch -and built the equivalent from living matter (M. B. Elowitz and S. Leibler Nature 403, 335-338 (2000) ; T. S. Gardner et al. Nature 403, 339-342; 2000) . Life became a machine. To many, including me, this was a profound moment: the beginning of the field of synthetic biology. Now an international enterprise with the potential to transform our lives, synthetic biology crosses age and organizational boundaries, and involves large corporations, small startups, academics and tinkerers.
In 52-56; 2010) . His lab inserted the genome of the bacterium Mycoplasma mycoides (synthesized and slightly modified) into a 'dead' cell of a closely related organism, revivifying its protoplasm (see N. Comfort Nature 502, 436-437; 2013) . Was the synthetic element in this process the use of carbon, hydrogen and oxygen from non-living sources? Was it that the inserted DNA had been built from a slightly altered sequence on a computer's hard drive? Or was it the act of creating a new biological cell by human intervention?
I do have quibbles. Roosth's focus is exclusively on US labs. The dearth of coverage of Europe -except for a passing comment on Dolly the sheep, cloned at the Roslin Institute outside Edinburgh, UK -makes Synthetic a little one-sided. There are other omissions. For example, Roosth hardly discusses the pioneering work by James Collins at Boston University in Massachusetts and his colleagues: they created one of the first synthetic circuits in a cell.
Yet the chapter on DIY synthbio is a welcome reminder of the excitement I remember from the late 1970s, when amateur groups helped to drive the desktopcomputer revolution. Hobbyist groups are still emerging in biology, such as the nonprofit SoundBio Lab, founded by synthetic biologist Michal Galdzicki, data scientist Zach Mueller and science educator Regina Wu in Seattle, Washington -my home town. I suspect that the main role of these organizations will not be in inventing new life, but in teaching the general public; less grand, but equally important.
Synthetic biology holds great promise in delivering new sources of energy and mat erials, therapeutics and, most exciting of all, regenerative medicine. What might stymie future development is funding. Currently, basic science funding in the United States is extremely uncertain; it could be dramatically curtailed in the next five years. Meanwhile, Europe and China are boosting their basic research in synthetic biology -and could eventually become dominant players. ■ Herbert Sauro is an associate professor in bioengineering at the University of Washington, Seattle. e-mail: hsauro@uw.edu
